Founders Capital Management »

Catalyst Pharmaceutical Partners shares owned by Founders Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Founders Capital Management from 13F filings

Historical chart of Founders Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Founders Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Founders Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 600 23.34
2025-09-30 $12k 600 19.70

More positions owned by Founders Capital Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Corning Incorporated (GLW)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Raytheon Technologies Corp (RTX)
Johnson & Johnson (JNJ)
Spdr Series Trust State Street Spd (SPYG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Lockheed Martin Corporation (LMT)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Abbvie (ABBV)
Applied Materials (AMAT)

View all positions for Founders Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners